Advertisement

International Journal of Public Health

, Volume 58, Issue 4, pp 547–553 | Cite as

Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socio-economic transitions (MedCHAMPS)—rationale and methods

  • Wasim MaziakEmail author
  • Julia Critchley
  • Shahaduz Zaman
  • Nigel Unwin
  • Simon Capewell
  • Kathleen Bennett
  • Belgin Unal
  • Abdullatif Husseini
  • Habiba Ben Romdhane
  • Peter Phillimore
Original Article

Abstract

Objectives

In response to the escalating epidemic of cardiovascular disease (CVD) in the Mediterranean Region (MR), an international collaboration aiming at understanding the burden of CVD and evaluating cost-effective strategies to combat it was recently established. This paper describes the rationale and methods of the project MedCHAMPS to disseminate this successful experience.

Methods

The framework of MedCHAMPS is exceptional in combining multiple disciplines (e.g. epidemiology, anthropology, economics), countries [Turkey, Syria, occupied Palestinian territory (oPt), Tunisia, UK, Ireland], research methods (situational and policy analysis, quantitative and qualitative studies, statistical modeling), and involving local stakeholders at all levels to assess trends of CVD/diabetes in the society and attributes of the local health care systems to provide optimal policy recommendations to reduce the burden of CVD/diabetes.

Results and conclusions

MedCHAMPS provides policy makers in the MR and beyond needed guidance about the burden of CVD, and best cost-effective ways to combat it. Our approach of building developed–developing countries collaboration also provides a roadmap for other researchers seeking to build research base into CVD epidemiology and prevention in developing countries.

Keywords

Cardiovascular disease Diabetes Mediterranean Region Trends Population Policies Interventions 

Notes

Acknowledgments

The Project MedCHAMPS is funded by EC FP7 (grant no 223075).

References

  1. Alwan AA (1993) Cardiovascular diseases in the eastern Mediterranean region. World Health Stat Q 46(2):97–100PubMedGoogle Scholar
  2. Beaglehole R, Yach D (2003) Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 362(9387):903–908PubMedCrossRefGoogle Scholar
  3. Capewell S, Beaglehole R, Seddon M, McMurray J (2000) Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 102(13):1511–1516PubMedCrossRefGoogle Scholar
  4. Critchley J, Liu J, Zhao D, Wei W, Capewell S (2004) Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 110(10):1236–1244PubMedCrossRefGoogle Scholar
  5. Ebrahim S, Smith GD (2001) Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol 30(2):201–205PubMedCrossRefGoogle Scholar
  6. Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD, Rodgers A, Murray CJ (2005) Rethinking the “diseases of affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med 2(5):e133PubMedCrossRefGoogle Scholar
  7. Ford E, Ajani U, Croft J, Critchley JA, Labarthe D, Kottke T (2007) Explaining the decrease in mortality from coronary heart disease in the United States between 1980 and 2000. N Engl J Med 356:2388–2398PubMedCrossRefGoogle Scholar
  8. International Diabetes Federation 2011, Diabetes Atlas. (http://www.idf.org/atlasmap/atlasmap). Accessed 16 Nov 2011
  9. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S (2005) Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 162(8):764–773PubMedCrossRefGoogle Scholar
  10. Maziak W (2006) Health in the middle East. BMJ 333(7573):815–816PubMedCrossRefGoogle Scholar
  11. Maziak W (2009) The crisis of health in a crisis ridden region. Int J Public Health 54(5):349–355PubMedCrossRefGoogle Scholar
  12. Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil U (2007) Cardiovascular health among adults in Syria: a model from developing countries. Ann Epidemiol 17(9):713–720PubMedCrossRefGoogle Scholar
  13. Murray CJ, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard Univ Press, BostonGoogle Scholar
  14. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: global Burden of Disease Study. Lancet 349(9064):1498–1504PubMedCrossRefGoogle Scholar
  15. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB (2003) Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361(9359):717–725PubMedCrossRefGoogle Scholar
  16. Nugent R (2008) Chronic diseases in developing countries: health and economic burdens. Ann N Y Acad Sci 1136:70–79PubMedCrossRefGoogle Scholar
  17. Reddy KS (2002) Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr 5(1A):231–237PubMedCrossRefGoogle Scholar
  18. Rodgers A, Vaughan P (2002) ‘World Health Report 2002: Reducing Risks, Promoting Healthy Life. World Health Organization, GenevaGoogle Scholar
  19. Rose G (1985) Sick individuals and sick populations. Int J Epidemiol 14(1):32–38PubMedCrossRefGoogle Scholar
  20. Unal B, Critchley JA, Capewell S (2004) Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109(9):1101–1107PubMedCrossRefGoogle Scholar
  21. World health Organization (1999) The world health report 1999: making a difference. WHO, GenevaGoogle Scholar
  22. World Health Organization 2011a, Diabetes Programme. [http://www.who.int/diabetes/en/]. Accessed 2 Dec 2011
  23. World Health Organization 2011b, ‘Obesity and overweight. Fact sheets. Available at: [http://www.who.int/mediacentre/factsheets/fs311/en/] Accessed 2 Dec 2011
  24. Yach D, Leeder SR, Bell J, Kistnasamy B (2005) Global chronic diseases. Science 307(5708):317PubMedCrossRefGoogle Scholar
  25. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104(22):2746–2753PubMedCrossRefGoogle Scholar

Copyright information

© Swiss School of Public Health 2012

Authors and Affiliations

  • Wasim Maziak
    • 1
    • 2
    Email author
  • Julia Critchley
    • 3
    • 4
  • Shahaduz Zaman
    • 4
  • Nigel Unwin
    • 5
  • Simon Capewell
    • 6
  • Kathleen Bennett
    • 7
  • Belgin Unal
    • 8
  • Abdullatif Husseini
    • 9
  • Habiba Ben Romdhane
    • 10
  • Peter Phillimore
    • 4
  1. 1.Syrian Center for Tobacco StudiesAleppoSyria
  2. 2.Department of Epidemiology, Robert Stempel College of Public Health and Social WorkFlorida International UniversityMiamiUSA
  3. 3.St George’s University of LondonLondonUK
  4. 4.Institute of Health and SocietyNewcastle UniversityNewcastle Upon TyneUK
  5. 5.Faculty of Medical Sciences, University of the West IndiesBarbadosWest Indies
  6. 6.University of LiverpoolLiverpoolUK
  7. 7.Trinity College DublinDublinIreland
  8. 8.Dokuz Eylul UniversityIzmirTurkey
  9. 9.Birzeit UniversityBirzeitOccupied Palestinian Territory
  10. 10.Faculté de Médecine de TunisTunisTunisia

Personalised recommendations